CD79B Antibodies

Santa Cruz Biotechnology offers a broad range of CD79B monoclonal antibodies for research focused on understanding CD79B in B cell signaling and development. CD79B monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD79B is a crucial component of the B cell receptor complex, playing a significant role in the activation and proliferation of B lymphocytes. CD79B functions as an essential element in proper immune response regulation, with its dysregulation linked to various hematological malignancies. Understanding CD79B mechanisms provides valuable insights for developing targeted therapies and advancing knowledge of immune system disorders. Researchers can utilize CD79B monoclonal antibodies to investigate cellular pathways and molecular interactions in immune system development. CD79B expression patterns can be effectively studied across different tissue types and cellular conditions. CD79B monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of immune system function and disease mechanisms.